Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Patients who have had hepatitis C or cirrhosis have a greater risk of developing HCC, said Manns. However, it is difficult to confirm if clearing the virus decreases risk of HCC because almost all patients diagnosed with hepatitis C or cirrhosis are treated for the viruses, leaving no control group to compare risk factors with.
New strategies for surveillance of HCC risk are needed, says Manns. These could include understanding the connections between age and having high-alpha one fetoprotein and HCC.
Time to Bladder Cancer Treatment Is Similar Among Black and White Patients, But Other Disparities Persist
Dr Jia on the Evolving Role of Metastasis-Directed Radiotherapy in Prostate Cancer
Dr Wang on the Limited Utility of Quantitative Molecular Imaging Thresholds in RCC
Darolutamide Use Is Routine in Both Doublets and Triplet Therapies in mHSPC
2 Commerce Drive
Cranbury, NJ 08512